Five apps powering the future of at-home HIV tests
The smartphone revolution is providing a promising tool to combat the human immunodeficiency virus (HIV)…
December 1, 2022 - 8 minutes
HIV
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the 1980s.…
December 1, 2022 - 8 minutes
AELIX Therapeutics publishes positive data on its HIV vaccine
Positive results from a clinical study into biotech company, AELIX’ Therapeutics’, HIV vaccine have been…
November 2, 2022 - 3 minutes
United BioPharma gets FDA approval for phase 2 HIV drug trial
Taiwan-headquartered United BioPharma (UBP) says the U.S. Food and Drug Administration (FDA) has approved a…
August 31, 2022 - 3 minutes
First patient receives new immunotherapy drug for HIV in clinical trial
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus…
July 12, 2022 - 3 minutes
Eight diseases CRISPR technology could cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
October 18, 2021 - 11 minutes
As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…
September 8, 2021 - 5 minutes
HIV Drug Approvals Lift Hopes Amid Missed UN Targets
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
February 4, 2021 - 6 minutes
ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for…
March 23, 2020 - 2 minutes
Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
December 6, 2019 - 2 minutes
ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed…
November 22, 2019 - 2 minutes
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
August 22, 2019 - 2 minutes
